Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
2019Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis
Behrens, F.; Koehm, M.; Schwaneck, E.C.; Schmalzing, M.; Wittig, B.M.; Gnann, H.; Greger, G.; Tony, H.P.; Burkhardt, H.
Journal Article
2019Characterization Of Patients With Inflammatory Bowel Disease In The Ankylosing Spondylitis Cohort Prior And During Adalimumab Treatment: Data From A Large German Non-Interventional Study
Köhm, M.; Schmalzing, M.; Schwaneck, E.C.; Gnann, H.; Tony, H.P.; Greger, G.; Boas, A.; Burkhardt, H.; Behrens, F.
Journal Article
2018Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab
Behrens, F.; Koehm, M.; Schwaneck, E.C.; Schmalzing, M.; Gnann, H.; Greger, G.; Tony, H.P.; Burkhardt, H.
Journal Article
2018Sicherheit und Wirksamkeitshinweise zum Off-label-Einsatz von Biologikatherapien nach Versagen konventioneller Therapien bei Patienten mit entzündlich rheumatischen Erkrankungen
Proft, F.; Schulze-Koops, H.; Grunke, M.; Schrezenmeier, E.; Halleck, F.; Henes, J.; Unger, L.; Schmidt, E.; Fiehn, C.; Jacobi, A.; Iking-Konert, C.; Kneitz, C.; Schmidt, R.E.; Bannert, B.; Voll, R.E.; Fischer-Betz, R.; Kötter, I.; Tony, H.P.; Holle, J.; Aringer, M.; Erler, A.; Behrens, F.; Burmester, G.R.; Dörner, T.
Journal Article
2017Impact of rituximab in combination with leflunomide and rituximab retreatment with two different dosages on patient-reported outcomes: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-STUDY)
Köhm, M.; Rossmanith, T.; Dauth, S.; Alten, R.; Aringer, M.; Backhaus, M.; Burmester, G.; Feist, E.; Kellner, H.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.P.; Wassenberg, S.; Burkhardt, H.; Behrens, F.
Journal Article
2016Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study
Behrens, F.; Rossmanith, T.; Koehm, M.; Alten, R.; Aringer, M.; Burmester, G.R.; Feist, E.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Wassenberg, S.; Tony, H.P.; Kellner, H.; Backhaus, M.; Burkhardt, H.
Journal Article
2016Minimal Disease Activity Is a Stable Measure of Therapeutic Response in Psoriatic Arthritis Patients Receiving Treatment with Adalimumab
Behrens, F.; Koehm, M.; Schwaneck, E.C.; Schmalzing, M.; Gnann, H.; Greger, G.; Tony, H.P.; Burkhardt, H.
Journal Article
2016Rituximab in combination with leflunomide: Results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (Amara-Study)
Behrens, F.; Rossmanith, T.; Köhm, M.; Alten, R.; Aringer, M.; Backhaus, M.; Baerwald, C.; Burmester, G.; Feist, E.; Kellner, H.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.P.; Wassenberg, S.; Burkhardt, H.
Journal Article
2016Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients
Englbrecht, M.; Alten, R.; Aringer, M.; Baerwald, C.G.; Burkhardt, H.; Eby, N.; Fliedner, G.; Gauger, B.; Henkemeier, U.; Hofmann, M.W.; Kleinert, S.; Kneitz, C.; Krueger, K.; Pohl, C.; Roske, A.-E.; Schett, G.; Schmalzing, M.; Tausche, A.-K.; Tony, H.P.; Wendler, J.
Journal Article
2015The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.
Feuchtenberger, M.; Kleinert, S.; Scharbatke, E.C.; Gnann, H.; Behrends, F.; Wittig, B.M.; Greger, G.; Tony, H.P.
Journal Article
2015Predictors of therapeutic response in ankylosing spondylitis patients initiating therapy with adalimumab in a german non-interventional study
Koehm, M.; Behrens, F.; Scharbatke, E.C.; Schmalzing, M.; Gnann, H.; Greger, G.; Wittig, B.; Tony, H.P.; Burkhardt, H.
Journal Article
2015SAT0070 Association of Improvement in Pain with Therapeutic Response as Determined by Individual Significant Improvement Criteria in Patients with Rheumatoid Arthritis
Scharbatke, E.; Behrens, F.; Schmalzing, M.; Koehm, M.; Greger, G.; Gnann, H.; Tony, H.P.; Burkhardt, H.
Journal Article
2014Effects of methotrexate on anti-TNF treatment in rheumatoid arthritis
Schmalzing, M.; Behrens, F.; Scharbatke, E.C.; Koehm, M.; Wittig, B.; Greger, G.; Burkhardt, H.; Tony, H.P.
Journal Article
2014SAT0358 impact of methotrexate on anti-TNF treatment in psoriatic arthritis? An in-depth analysis of a large prospective observational study with adalimumab
Behrens, F.; Köhm, M.; Arndt, U.; Wittig, B.; Greger, G.; Thaci, D.; Scharbatke, E.; Tony, H.P.; Burkhardt, H.
Journal Article